Genpharmasec Limited (BOM:531592)
India flag India · Delayed Price · Currency is INR
1.080
-0.040 (-3.57%)
At close: Mar 9, 2026

Genpharmasec Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2020 - 2016
Market Capitalization
5981,0091,2358611,5232,218
Upgrade
Market Cap Growth
-49.98%-18.31%43.41%-43.45%-31.34%-21.03%
Upgrade
Enterprise Value
6571,0211,2218051,4472,067
Upgrade
Last Close Price
1.081.892.231.873.304.81
Upgrade
PE Ratio
-81.93-76.55-176.37
Upgrade
PS Ratio
0.612.994.063.385.5710.41
Upgrade
PB Ratio
0.911.551.915.629.9110.73
Upgrade
P/TBV Ratio
1.261.551.925.629.9110.73
Upgrade
P/OCF Ratio
-33.78----
Upgrade
EV/Sales Ratio
0.673.034.013.155.309.70
Upgrade
EV/EBITDA Ratio
--5926.15300.20-173.03
Upgrade
EV/EBIT Ratio
--31302.23324.00-174.86
Upgrade
Debt / Equity Ratio
0.170.080.060.20--
Upgrade
Debt / EBITDA Ratio
-82.1984.5411.50--
Upgrade
Net Debt / Equity Ratio
0.09-0.01-0.28-0.04-0.39-0.69
Upgrade
Net Debt / EBITDA Ratio
-2.062.34-868.31-2.1411.40-11.99
Upgrade
Net Debt / FCF Ratio
-0.356.040.192.456.67
Upgrade
Asset Turnover
-0.450.671.231.110.81
Upgrade
Inventory Turnover
-3.992.932.754.224.79
Upgrade
Quick Ratio
-2.0211.584.542.023.05
Upgrade
Current Ratio
-2.7815.169.173.433.74
Upgrade
Return on Equity (ROE)
-1.90%-0.42%7.33%-1.16%6.33%
Upgrade
Return on Assets (ROA)
--0.62%0.01%0.75%-1.35%2.81%
Upgrade
Return on Invested Capital (ROIC)
-4.89%-0.88%-0.01%1.82%-6.79%9.60%
Upgrade
Return on Capital Employed (ROCE)
--1.10%0.00%1.40%-3.50%5.70%
Upgrade
Earnings Yield
-0.77%1.22%-0.14%1.31%-0.14%0.57%
Upgrade
FCF Yield
--2.70%-2.40%-3.57%-1.59%-0.97%
Upgrade
Buyback Yield / Dilution
--80.25%-10.96%--2.06%46.25%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.